Urological Management of Extramural Malignant Ureteric Obstruction: A Survey of Irish Urologists
Authors:
Open Access
- 1 November 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Current Urology
- Vol. 11 (1) , 21-25
Abstract
Introduction: The absence of guidelines in the management of extramural malignant ureteric obstruction leads to confusion in decision making and in the interaction between urology and other clinical disciplines. In this study, we surveyed consultant urologists with the goal of achieving a better consensus on optimal management options. Methods: A multiple choice survey was sent via the online survey tool “SurveyMonkey” to all consultant urologists practicing in the Republic of Ireland. Results: There was a response rate of 57.5% (n = 23). Twenty-two (96%) consultants consider the use of percutaneous nephrostomy with placement of antegrade ureteric stent but only 22% (n = 5) would consider using a metallic stent. Eleven (48%) respondents favor retrograde stenting in the first instance with an equal proportion choosing an antegrade method. Nine (39%) consultants perform the initial stent change at 4-6 months, 8 (35%) at 2-4 months, and 1 at < 2 months and 6-10 months respectively. Total 59% (n = 13) of respondents felt that the duration of expected patient survival influenced their decision and agreement to stent with 42% (n = 8) saying this survival would need to be > 6 months and 82% (n = 18) were generally happy with the level of ongoing communication between urology and the primary service managing the patient. Conclusion: There is a lack of consensus regarding the management of this challenging problem, particularly with regard to timing of first stent change and whether to initially use an antegrade or retrograde approach. This reflects the heterogeneous patient cohort and the important factors of life expectancy and patient co-morbidities.Keywords
This publication has 14 references indexed in Scilit:
- Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstructionWorld Journal of Nephrology, 2016
- Metallic ureteral stents in malignant ureteral obstruction: short-term results and radiological features predicting stent failure in patients with non-urological malignanciesWorld Journal of Urology, 2013
- Long-Term Results of Metallic Stents for Malignant Ureteral Obstruction in Advanced Cervical CarcinomaJournal of Endourology, 2013
- Endourologic Management of Malignant Ureteral Obstruction: Indications, Results, and Quality-of-Life IssuesJournal of Endourology, 2010
- Management of Ureteral Obstruction Due to Advanced Malignancy: Optimizing Therapeutic and Palliative OutcomesJournal of Urology, 2008
- Retrograde Ureteral Stents for Extrinsic Ureteral Obstruction: Nine Years’ Experience at University of MichiganUrology, 2007
- The outcome with ureteric stents for managing non‐urological malignant ureteric obstructionBJU International, 2007
- CURRENT OPINION AMONGST RADIOLOGISTS AND UROLOGISTS IN THE UK ON PERCUTANEOUS NEPHROSTOMY AND URETERIC STENT INSERTION FOR ACUTE RENAL UNOBSTRUCTION: RESULTS OF A POSTAL SURVEYBJU International, 2006
- Retrograde or antegrade double-pigtail stent placement for malignant ureteric obstruction?Clinical Radiology, 2005
- Outcome of palliative urinary diversion in the treatment of advanced malignanciesCancer, 1999